GENERAL: FPH: FISHER & PAYKEL HEALTHCARE INTRODUCES NEW CPAP RANGE
10 Mar 2010 9:58 am
FPH
10/03/2010
GENERAL
REL: 0957 HRS Fisher & Paykel Healthcare Corporation Limited
GENERAL: FPH: FISHER & PAYKEL HEALTHCARE INTRODUCES NEW CPAP RANGE
FISHER & PAYKEL HEALTHCARE INTRODUCES NEW CPAP RANGE
Auckland, New Zealand, 10 March 2010 - Fisher & Paykel Healthcare Corporation
Limited (NZSX:FPH, ASX:FPH) announced today that it has introduced into
Australia and New Zealand its new ICON continuous positive airway pressure
(CPAP) devices for the treatment of obstructive sleep apnea (OSA).
The ICON range integrates Fisher & Paykel Healthcare's leading technologies
into stylish, compact and intelligent devices to deliver a better night's
sleep for OSA patients. The F&P ICON also includes a digital clock, alarm
and music playing capabilities to enhance patient adaptation to CPAP therapy.
"The ICON combines both exceptional style and technology to fit unobtrusively
into the home setting. It has a very small footprint and incorporates our
innovative technologies including, SmartStick, ThermoSmart and SensAwake",
commented Michael Daniell, Fisher & Paykel Healthcare's Chief Executive
Officer.
The product range spans three models; Auto, Premo and Novo. The Auto detects
interruptions to normal breathing and provides the appropriate positive
airway pressure to meet the breath-by-breath needs of the patient with full
efficacy and compliance reporting. The Premo model provides fixed pressure
therapy with efficacy and compliance reporting, while the Novo provides basic
compliance reporting.
The ICON range also includes Fisher & Paykel's InfoSmart technologies, which
will provide a full range of communication and compliance reporting options.
"We are delighted with the positive response to ICON from CPAP users,
clinicians and home care providers and we are looking forward to
progressively introducing the range into our international markets this
year", concluded Mr Daniell.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer
of products and systems for use in respiratory care, acute care and the
treatment of obstructive sleep apnea. The company's products are sold in
over 120 countries worldwide. For more information about the company visit
www.fphcare.com.
Contact: Michael Daniell MD/CEO on +64 9 574 0161 or Tony Barclay CFO on +64
9 574 0119. For high resolution images please contact
Glenda.Jones@fphcare.co.nz.
End CA:00192305 For:FPH Type:GENERAL Time:2010-03-10:09:58:05 More announcements for FPH
|
|


NZX 15 Index
| |
FREE Email News
Today's Market Numbers
| NZX 50 Index |
3350.44 |
 |
23.70 |
| S&P/ASX 200 |
4259.70 |
 |
23.20 |
| Dow Jones Industrials |
12890.50 |
 |
6.50 |
Stock Quote
Most Commented On
|